These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3599278)

  • 1. Responsiveness of vein bypass grafts to stimulation with norepinephrine and 5-hydroxytryptamine.
    Makhoul RG; Davis WS; Mikat EM; McCann RL; Hagen PO
    J Vasc Surg; 1987 Jul; 6(1):32-8. PubMed ID: 3599278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reversibility of canine vein-graft arterialization.
    Fann JI; Sokoloff MH; Sarris GE; Yun KL; Kosek JC; Miller DC
    Circulation; 1990 Nov; 82(5 Suppl):IV9-18. PubMed ID: 2225440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses.
    Park TC; Harker CT; Edwards JM; Moneta GL; Taylor LM; Porter JM
    J Vasc Surg; 1993 Jul; 18(1):61-8; discussion 68-9. PubMed ID: 8326660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
    Huynh TT; Iaccarino G; Davies MG; Svendsen E; Koch WJ; Hagen PO
    Surgery; 1998 Aug; 124(2):177-86. PubMed ID: 9706136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
    Massey MF; Davies MG; Svendsen E; Klyachkin ML; Schwartz LB; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 Jun; 54(6):530-8. PubMed ID: 8412062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serotonergic receptor expression in experimental vein grafts.
    Radic ZS; O'Donohoe MK; Schwartz LB; Stein AD; Mikat EM; McCann RL; Hagen PO
    J Vasc Surg; 1991 Jul; 14(1):40-7. PubMed ID: 2061959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
    Kodama A; Komori K; Kajikuri J; Itoh T
    J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and function of G-proteins in experimental intimal hyperplasia.
    Davies MG; Ramkumar V; Gettys TW; Hagen PO
    J Clin Invest; 1994 Oct; 94(4):1680-9. PubMed ID: 7929847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts.
    O'Donohoe MK; Schwartz LB; Radic ZS; Mikat EM; McCann RL; Hagen PO
    Ann Surg; 1991 Dec; 214(6):727-32. PubMed ID: 1741654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic hypertension alters vasomotor function in experimental vein grafts.
    O'Donohoe MK; Radic ZS; Schwartz LB; Mikat EM; McCann RL; Hagen PO
    J Vasc Surg; 1991 Jul; 14(1):30-9. PubMed ID: 2061958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
    Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of cryopreserved veins. Preliminary report.
    Brockbank KG; Donovan TJ; Ruby ST; Carpenter JF; Hagen PO; Woodley MA
    J Vasc Surg; 1990 Jan; 11(1):94-100; discussion 100-2. PubMed ID: 2296107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
    Davies MG; Klyachkin ML; Dalen H; Svendsen E; Hagen PO
    Surgery; 1993 Aug; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
    Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
    J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of alpha1-adrenergic receptors in experimental vein grafts.
    Davies MG; Huynh TT; Hagen PO
    J Surg Res; 1999 Jun; 84(1):40-5. PubMed ID: 10334887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.